Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herba Leonuri injection versus oxytocin for prevention of postpartum hemorrhage and promotion of uterine involution
ChiCTR-TRC-08000136Phase 4Completed
- Sponsor
- Renji Hospital
- Start
- Jul 2004
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of yimucao and oxytocin in postpartum hemorrhage (PPH) and postabortion hemorrhage (PAH) (3 arms), sponsored by Renji Hospital. Primary endpoints: Vaginal bleeding quantity during operation, Vaginal bleeding quantity within 2 hours after operation and 4 more. Started Jul 2004; status: completed.
02
Drugs
yimucaooxytocin
03
Conditions
postpartum hemorrhage (PPH)postabortion hemorrhage (PAH)
Beyond the preview
Go deeper on ChiCTR-TRC-08000136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000136.